Artemis Therapeutics Inc.
Artemis Therapeutics Inc. (ATMS) Stock Overview
Key statistics and deep links to earnings, valuation, revenue, dividends, and more.
FMP · ATMS · as of Jun 8, 2026
Key Statistics
Explore Artemis Therapeutics Inc. Data
atms stock data · financialsFinancial Snapshot
Full FinancialsCompetitors & Peers
atms competitorsATMS
AOAO
BHAC
CLOE
IRAA
JMTMStock Performance
Full HistoryAbout Artemis Therapeutics Inc.
Artemis Therapeutics Inc. currently lacks substantial business operations. Situated in New York, New York, this company previously concentrated on developing pharmaceutical agents to prevent and treat…
what is artemis therapeutics inc. · atms stock overview · artemis therapeutics inc. company profile · who is artemis therapeutics inc. ceo · atms OTC · artemis therapeutics inc. headquarters · artemis therapeutics inc. business segments
About Stock Overview & Key Data
Artemis Therapeutics Inc. (ATMS) is a Financial Services company in the Shell Companies industry, listed on OTC since Feb 17, 1998. As of the latest trading session, ATMS stock price is $0.50, with a market capitalization of $55.8M. The stock has returned -86.72% over the past 12 months and -57.07% year-to-date.
In fiscal year 2022, Artemis Therapeutics Inc. reported revenue of $311000.00. For detailed financial data including revenue history, earnings, and balance sheet — use the tabs above.
Frequently Asked Questions
As of the latest trading session, Artemis Therapeutics Inc. (ATMS) stock price is $0.50. The stock is traded on OTC under the ticker symbol ATMS. The 52-week range is $0.11 – $4.50.